Aurora kinase inhibitors: an updated patent review (2021–present)

Yao-Sheng Zhang, Hong-Yu Zhang, Junmin Zhang, Shi-Wu Chen

Open source

DOI
10.1080/13543776.2026.2733162
Published
2026-09-17
Container
Expert Opinion on Therapeutic Patents
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13543776.2026.2733162,
  title = {Aurora kinase inhibitors: an updated patent review (2021–present)},
  author = {Yao-Sheng Zhang and Hong-Yu Zhang and Junmin Zhang and Shi-Wu Chen},
  year = {2026},
  journal = {Expert Opinion on Therapeutic Patents},
  doi = {10.1080/13543776.2026.2733162},
  url = {https://doi.org/10.1080/13543776.2026.2733162}
}

RIS

TY  - JOUR
TI  - Aurora kinase inhibitors: an updated patent review (2021–present)
AU  - Yao-Sheng Zhang
AU  - Hong-Yu Zhang
AU  - Junmin Zhang
AU  - Shi-Wu Chen
PY  - 2026
JO  - Expert Opinion on Therapeutic Patents
DO  - 10.1080/13543776.2026.2733162
UR  - https://doi.org/10.1080/13543776.2026.2733162
ER  - 

APA

Zhang, Y., Zhang, H., Zhang, J., & Chen, S. (2026). Aurora kinase inhibitors: an updated patent review (2021–present). Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2026.2733162

Source records